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PR ESEN TATION OF C A SE
Dr. Nancy Cibotti-Granof (Medicine): A 46-year-old woman with end-stage renal disease 
was seen by a rheumatology consultant because of stiffness of her joints and skin.
The patient had been well except for mild asthma until 7 years earlier, when 
group A streptococcal pneumonia developed, complicated by septic shock, with 
acute respiratory distress syndrome; septic emboli to the lungs, brain, and kidney; 
renal failure requiring dialysis; f laccid quadriplegia; and coma. On the 25th day 
after initial admission to another hospital, she was transferred to this hospital 
while she was receiving mechanical ventilation.
As part of the evaluation during admission, computed tomography (CT) of the 
thorax, abdomen, and pelvis with intravenous contrast revealed cavitary lesions in 
the right lower lobe of the lung, with diffuse bilateral ground-glass opacities, 
small bilateral pleural effusions, and multiple prominent mediastinal lymph nodes. 
CT of the head revealed regions of cortical mineralization in the left posterior frontal 
lobe and the right parietal lobe, with surrounding hypodensity consistent with 
edema and minimal enhancement consistent with cerebritis. Magnetic resonance 
imaging (MRI) of the brain with gadolinium revealed regions of cortical enhance-
ment with surrounding edema in the left posterior frontal lobe and right parietal 
lobe consistent with cerebritis and vasculitis, as well as a small infarct in the right 
corona radiata (Fig. 1A).
Follow-up CT scans with contrast enhancement and MRI studies with gadolinium 
enhancement revealed regions of cerebritis and small infarcts, with no drainable 
abscesses. Transthoracic and transesophageal echocardiography showed a patent 
foramen ovale, normal left ventricular function, and no valvular vegetations. A filter 
was placed in the inferior vena cava.
During the hospital stay, the blood pressure stabilized; the patient regained 
consciousness and recovered speech and motor strength, with residual right-sided 
weakness. Kidney function improved, and hemodialysis was discontinued. Weak-
ness, sensory loss, and pain in both feet persisted, and treatment with gabapentin 
(300 mg twice daily) was begun. The patient was discharged on the 53rd hospital 
day, first to a rehabilitation facility for 2 months, and then to home. Follow-up MRI 
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of the brain with gadolinium enhancement re-
vealed abnormalities consistent with previous 
cerebritis.
During the course of the next 2 years, the pa-
tient resumed most activities. Mild right-sided 
weakness and painful neuropathy persisted, 
which were managed with gabapentin and acet-
aminophen with codeine. Chronic kidney disease 
persisted, with serum creatinine levels ranging 
from 2.4 to 3.5 mg per deciliter (212.2 to 309.4 
μmol per liter). The renal failure was associated 
with edema of both feet and legs, which was treat-
ed with diuretics, and anemia, which was treated 
intermittently with recombinant erythropoietin 
(epoetin alfa). She was admitted to the hospital 
on several occasions because of respiratory dis-
tress; these episodes were thought to be exacerba-
tions of asthma. Several episodes of atrial fibril-
lation occurred. Chest radiography, performed on 
admission for shortness of breath 4.5 years be-
fore the current admission, revealed fullness of 
the right paratracheal area, and CT of the chest 
showed enlarged mediastinal and hilar lymph 
nodes, hazy ground-glass opacities in both lungs, 
and scarring or atelectasis in both upper lobes, 
the lingula, and the right middle lobe. Four 
years before admission, dryness of the skin of the 
hands and feet developed, as did pain and stiff-
ness in the hands, elbows, and knees that was 
worse in the morning.
Twenty-two months before admission, she re-
ported worsening shortness of breath over the 
past 6 months and having to rest after walking 
50 ft. On evaluation, oxygen saturations of 82 to 
84% were noted after exertion while she was 
breathing ambient air. Chest CT revealed a marked 
increase in the size and number of mediastinal 
lymph nodes and stable ground-glass opacities. 
Treatment was begun at home with 40 mg of 
prednisone daily and supplemental oxygen; her 
symptoms improved slightly, and bronchoscopy 
and mediastinoscopy were scheduled. Results of 
laboratory tests are shown in Table 1. On the day 
of the scheduled bronchoscopy, she reported in-
creased shortness of breath, with more frequent 
use of home oxygen and nebulizers; the proce-
dure was canceled and she was admitted to the 
hospital.
The pulse was 100 beats per minute and the 
respiratory rate 24 breaths per minute; oxygen 
saturation was 93% while the patient was breath-
ing oxygen at 3 liters per minute by nasal can-
nula, and there was pitting edema (2+) of the feet 
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Figure 1. Radiology Imaging Studies.
An axial T1-weighted image of the patient’s brain (Panel 
A) from magnetic resonance imaging performed on her 
first admission, with gadolinium contrast, demonstrates 
regions of gyriform enhancement with surrounding edema 
in the right parietal lobe and posterior left frontal lobe 
(arrows). The appearance is consistent with cerebritis. 
Computed tomographic scanning of the chest without 
contrast (Panel B), performed 22 months before the pa-
tient’s admission, shows enlarged lymph nodes present 
on soft-tissue windows. T ere has been interval develop-
ment of patchy opacities (Panel C, arrow) superimposed 
on ground-glass opacification of the lung parenchyma.
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and legs. Intravenous furosemide was adminis-
tered. Repeated CT of the chest (Fig. 1B and 1C) 
revealed progression of diffuse ground-glass 
changes with new soft-tissue opacities in both 
lungs and stable diffuse mediastinal and hilar 
lymphadenopathy. Pulmonary-function tests re-
vealed a forced expiratory volume in 1 second 
(FEV1) of 0.44 liter (15% of the predicted value) 
and a forced vital capacity (FVC) of 0.77 liter (22% 
of the predicted value), findings that were consis-
tent with a severe combined obstructive and re-
strictive defect. The pathological examination of 
specimens of lung and paratracheal lymph nodes 
obtained on a subsequent biopsy revealed pulmo-
nary hemosiderosis; dendriform ossification; ex-
tensive fibrosis of the lymph nodes with scattered 
giant cells, histiocytes, and poorly formed gran-
ulomas; and no evidence of cancer. The findings 
were thought to be caused by sarcoidosis, and 
thus the dosage of prednisone was increased to 
60 mg daily. Her symptoms improved and she 
was discharged on the 10th day to continue pred-
nisone on a tapering dose, along with supplemen-
tal oxygen at home.
Eighteen months before the current admis-
sion, her weight had increased by 7 kg; dyspnea 
and pedal edema increased, and the woman was 
readmitted to this hospital. Chest radiography 
showed small bilateral pleural effusions. Atrial 
fibrillation followed by transient asystole oc-
curred; a diagnosis of the sick sinus syndrome 
was made and a pacemaker was placed. Labora-
tory test results are shown in Table 1. The pa-
tient was evaluated for possible lung and renal 
Table 1. Results of Laboratory Tests.*
Test
Reference Range, 
Adults†
22 Mo before  
Admission
18 Mo before  
Admission
17 Mo before  
Admission On Admission
Rheumatoid factor (IU/ml) <30 <30
Autoantibodies
Antinuclear antibody Negative at 1:40  
dilution
Positive at 1:320 dilution, 
speckled pattern
Anti–double-stranded (native) DNA Negative Negative
Anti–Ro (SSA) antibody Negative Negative
Anti–La (SSB) antibody Negative Negative
Anti–Smith antibody Negative Negative
Anti–RNP antibody Negative Negative
Anti–Scl-70 antibody Negative Negative
Antineutrophil cytoplasmic antibody Negative Negative
Anticardiolipin IgM (MPL units) 0–15 33.7 41.0
Anticardiolipin IgG (GPL units) 0–15 4.7 3.5
Partial-thromboplastin time–lupus 
 anticoagulant
Negative Negative
Goodpasture’s antigen Negative Negative
Heparin–PF4 antibody Positive for heparin- 
induced thrombo-
cytopenia (type 2)
Serum protein electrophoresis Normal pattern
Immunofixation No M component 
detected
IgG (mg/dl) 614–1295 1190
IgA (mg/dl) 69–309 268
IgM (mg/dl) 53–334 301
* GPL denotes IgG phospholipid, and MPL IgM phospholipid.
† Reference values are affected by many variables, including the patient population and the laboratory methods used. The ranges used at 
Massachusetts General Hospital are for adults who are not pregnant and who do not have medical conditions that could affect the results. 
Therefore, they may not be appropriate for all patients.
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transplantation. Magnetic resonance angiography 
with gadolinium enhancement revealed small re-
nal arteries without significant stenosis. Cardiac 
catheterization demonstrated cardiac output of 
8.4 liters per minute by thermodilution and se-
verely elevated right heart pressures with a high 
wedge pressure (30 mm Hg). After diuresis, her 
weight returned to baseline; her symptoms re-
solved, and she was discharged. Two weeks later, 
pathological examination of an endomyocardial 
biopsy specimen showed active and organizing 
fibrosis; no amyloid, iron, or organisms were seen 
on special stains.
Fifteen months before the current evaluation, 
the serum urea nitrogen level was 78 mg per 
deciliter (27.8 mmol per liter) and the creatinine 
level 3.2 mg per deciliter (282.9 μmol per liter). 
An arteriovenous fistula was created in the arm, 
and hemodialysis was begun. In the following 
month, the fistula clotted, and a right internal 
jugular catheter was placed. Subsequent attempts 
to place a peritoneal catheter failed because of 
infections. During the next 14 months, the patient 
was admitted on numerous occasions because of 
episodes of dyspnea, fluid overload, and periph-
eral edema, and also with infections associated 
with dialysis.
Two weeks before the current evaluation, she 
saw a neurologist for an evaluation of her chronic 
pain. On examination, her skin appeared taut and 
glassy, with focal ulcerations and abrasions; there 
was sensory loss in the lower legs, with decreased 
position and vibratory sense in the toes. Con-
sultation with a rheumatologist was suggested. 
Ten days later, the patient was readmitted to 
this hospital because of fever due to an infection 
at the site of the hemodialysis catheter; the cath-
eter was removed, and she received antibiotic 
treatment. The infection resolved, and the cath-
eter was replaced on the third day. The same 
day, she was seen by the rheumatology service.
The patient reported that the skin of her hands 
and feet had become dry and tight approximately 
4 years earlier, with pruritus and scratching that 
resulted in excoriation. The skin did not change 
color in the cold, although the symptoms were 
worse in the cold. Pain and stiffness in her 
joints had begun at the same time and involved 
her shoulders, elbows, knees, and interphalan-
geal joints. The pain and stiffness were worse on 
awakening, improved during the day, and were 
not associated with redness or warmth. The ar-
thralgias and skin changes had worsened during 
the past 3 years. She did not have heartburn or 
difficulty swallowing.
The patient had had asthma since childhood; 
a diagnosis of obstructive sleep apnea had been 
made 51∕2 years earlier, and she had subsequently 
received treatment with continuous positive air-
way pressure; since her illness 7 years earlier, 
she had had depression and emotional lability. 
A diagnosis of lumbar spinal stenosis had been 
made 3 years earlier. She lived with her husband 
and two children, who were healthy. She did not 
smoke, drink alcohol, or use illicit drugs. Her 
father had had lymphoma; her mother had had 
colon cancer at 55 years of age, and one of her 
grandparents had had a stroke. She had a history 
of heparin-induced thrombocytopenia and aller-
gies to penicillin, oxycodone-acetaminophen, and 
verapamil. Her medications included warfarin, 
montelukast sodium, ipratropium bromide by in-
haler, furosemide, gabapentin, sertraline, a multi-
vitamin, and sevelamer hydrochloride.
On examination, the patient was obese and 
appeared chronically ill. The vital signs were nor-
mal and the oxygen saturation was 94% while 
she was breathing 2 liters of oxygen by nasal 
cannula. Breath sounds were decreased in both 
lungs, without wheezing. There were abdominal 
scars, 3+ edema of both legs, and a clotted arte-
riovenous graft in the left arm. The skin was 
hyperpigmented, tight, hard, and dry on both 
arms and legs to the elbows and knees. There 
were flexion contractures on the hands, worse on 
the right than on the left. Shoulder abduction was 
limited by pain, more on the left than on the 
right; elbow extension was normal bilaterally, and 
extension at the knees was slightly decreased. The 
remainder of the examination was normal. The 
plasma level of creatinine was 3.1 mg per decili-
ter (274.0 μmol per liter; normal, <132.6 μmol 
per liter) and of urea nitrogen was 48 mg per 
deciliter (17.1 mmol per liter; normal range, 3.6 to 
7.1 mmol per liter). Results of other tests are 
shown in Table 1.
A diagnostic procedure was performed.
DIFFER EN TI A L DI AGNOSIS
Dr. Hasan Bazari: I cared for this patient and am 
aware of the diagnosis. This 46-year-old woman 
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lived through a severe illness characterized by 
sepsis, the acute respiratory distress syndrome, 
and septic emboli to multiple organs — includ-
ing the brain and the kidney. The renal injury was 
probably related to sepsis, embolic disease, expo-
sure to contrast media, and nephrotoxicity from 
antibiotics. Immune-complex glomerulonephri-
tis can occur in the setting of widespread infec-
tion, with the classic example being endocardi-
tis. Nonetheless, she recovered from the illness 
with remarkable renal and neurologic function 
and was able to function independently. She then 
had a gradual decline over many years. We con-
fronted the question of whether her decline was 
related to the sequelae of the previous illness or 
to the emergence of a new disease entity.
Peripheral neuropathy
This patient’s initial illness was followed by per-
sistent painful neuropathy. The differential diag-
nosis of neuropathy is broad, and some causes 
are summarized in Table 2. Diabetes mellitus, 
toxins, and vitamin deficiencies were ruled out. 
There was no evidence of vasculitis, cryoglobuli-
nemia, or Sjögren’s syndrome.1-3 Paraproteinemia, 
in which monoclonal proteins may be directed 
against myelin-associated glycoprotein,4,5 was not 
found. Medications were not implicated.6 Finally, 
renal failure itself can be associated with axonal 
neuropathy,7 paresthesias, reduction in deep-ten-
don reflexes, impaired vibration sense, muscle 
wasting and weakness, as well as with autonom-
ic neuropathy.8
The cause of this patient’s neuropathy was 
never clear, but we believed it was an unusual 
sequela of her episode of septic shock and her 
chronic kidney disease.
Respiratory failure
The need for supplemental oxygen slowly devel-
oped in this patient. The considerations to explain 
this requirement included the progression of ob-
structive sleep apnea, congestive heart failure in 
the setting of both anemia and chronic kidney 
disease, and a primary pulmonary process such 
as idiopathic pulmonary fibrosis. In cases of idio-
pathic pulmonary fibrosis, the course is usually 
more relentlessly progressive. Secondary causes 
such as Goodpasture’s syndrome, collagen vascu-
lar diseases such as scleroderma and lupus, and 
asbestosis resulting from occupational exposures 
should be ruled out. It was also possible that this 
problem was due to recurrent or progressive fluid 
overload. The patient did not have clear signs of a 
systemic disease such as lupus. She did have anti-
phospholipid antibodies, which can be associat-
ed with acute pulmonary capillaritis. Chronic 
pulmonary emboli could be related to her hyper-
coagulable state, but she was receiving adequate 
anticoagulant treatment.
The oxygen saturation values fell when the pa-
tient was walking, which raised the worrisome 
possibility of an interstitial lung disease. The 
presence of mediastinal and hilar lymphadenopa-
thy, together with the ground-glass opacities, 
made us suspect a primary pulmonary process. 
A search for a treatable cause led to a lung biopsy, 
which showed pulmonary hemosiderosis and fi-
brosis of the lymph nodes, with scattered giant 
cells and poorly formed granulomas.
Granulomatous Pulmonary Disease
Was the clinical diagnosis of sarcoidosis justi-
fied? The presence of granulomas supported the 
diagnosis,9 but granulomatous disease in the lung 
can be caused by a wide variety of illnesses in-
cluding tuberculosis, nontuberculous mycobac-
terial infections, fungi, other granulomatous in-
Table 2. Causes of Peripheral Neuropathy.*
Category Example
Metabolic disorders Diabetes mellitus
Toxins Ethanol
Vitamin deficiencies B12, folate
Vasculitis and autoimmune 
 diseases
Cryoglobulinemia, the Churg–Strauss  
syndrome, Sjögren’s syndrome
Amyloidosis AL, AA, transthyretin, beta2-microglobulin
Paraproteinemia-associated  
neuropathy
POEMS syndrome, CIDP
Paraneoplastic syndromes Anti–Hu-antibody–related neuropathy
Familial Hereditary sensory neuropathy, Charcot–
Marie–Tooth disease
Immune-mediated disorders Guillain–Barré syndrome, CIDP
Medications Thalidomide, pyridoxine, leflunomide
Renal failure —
Infections Syphilis, leprosy
* CIDP denotes chronic inflammatory demyelinating polyradiculoneuropathy, 
and POEMS polyneuropathy, organomegaly, endocrinopathy, monoclonal 
gammopathy, and skin changes.
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fections including those caused by bacteria and 
dirofilaria, as well as noninfectious causes includ-
ing sarcoidosis, berylliosis, talcosis, Wegener’s 
granulomatosis, the Churg–Strauss syndrome, 
necrotizing sarcoid granulomatosis, bronchocen-
tric granulomatosis, aspiration pneumonia, and 
rheumatoid nodules.10 With no support for these 
diagnoses, a tentative diagnosis of sarcoidosis 
was made, and the patient received treatment with 
60 mg of prednisone daily, with some improve-
ment in her symptoms.
Congestive heart failure
Congestive heart failure developed in the setting 
of atrial fibrillation and the sick sinus syndrome. 
The development of disease of the conduction 
system in a young person suggests an infiltrative 
process. Sarcoidosis of the heart can involve the 
conduction system, and it can lead to a restrictive 
cardiomyopathy with diastolic dysfunction. In-
deed, right heart catheterization confirmed the 
presence of high pulmonary-artery wedge pres-
sure. This could have been related to fluid over-
load or anemia, but it suggests that there must 
have been some diastolic dysfunction. The detec-
tion of granulomas on cardiac biopsy has a rela-
tively low sensitivity (20 to 30%), so the negative 
results from the endomyocardial biopsy do not 
rule out this diagnosis.11 Although a diagnosis of 
sarcoidosis could explain the pulmonary and 
cardiac disease, peripheral-nerve involvement is 
unusual in sarcoidosis.12
Amyloidosis
Systemic amyloidosis13 can cause a restrictive car-
diomyopathy, disease of the conduction system, 
and peripheral neuropathy. AL amyloidosis relat-
ed to immunoglobulin light chains is typically 
associated with a clonal plasma-cell disorder, 
with or without overt myeloma or lymphoma. AA 
amyloidosis can be seen in chronic infections such 
as osteomyelitis or tuberculosis as well as chronic 
inflammatory diseases. This patient’s initial in-
fection was successfully treated, and there was 
no evidence of a chronic smoldering infection. 
Beta2-microglobulin amyloidosis can develop in 
patients with end-stage renal disease who are 
undergoing dialysis.14 This form of amyloidosis 
has a propensity for deposition in joints and 
bones, leading to cyst formation, as well as carpal 
tunnel syndrome. Clinically significant cardiac 
involvement is very unusual. All types of amyloi-
dosis were ruled out by the right heart biopsy, 
which also ruled out unlikely diagnoses such as 
hemochromatosis and glycogen storage diseases.
The POEMS syndrome (polyneuropathy, or-
ganomegaly, endocrinopathy, monoclonal gam-
mopathy, and skin changes) can be associated 
with neuropathy, skin thickening, and lymph-
adenopathy.15 However, the lymph-node biopsy 
did not show evidence of osteosclerotic myeloma, 
a monoclonal (M) component, or an endocrinopa-
thy. Castleman’s disease was also ruled out by 
the findings on the same biopsy. The cardiac 
biopsy showed fibrosis. An earlier episode of 
myocarditis with residual fibrosis is a consider-
ation in this setting, as is ischemic injury to the 
myocardium. Uremic pericarditis could have led 
to constrictive pericarditis, but this condition was 
not detected in the right heart catheterization and 
seemed highly improbable.
For those who cared for this patient, it was 
difficult to explain the subsequent deterioration 
in her condition. Occam’s razor would mandate 
that all the clinical features be drawn together 
to a unifying diagnosis. We were unable to recog-
nize the common thread. Increasing skin thicken-
ing and joint contractures developed with time, 
which eventually led to consultation with the 
rheumatology department.
Dr. Jonathan Kay: I participated in this patient’s 
care and am aware of the diagnosis. Three years 
after her initial hospitalization, this patient ob-
served dryness and tightening of the skin on her 
distal arms and legs, with pruritus. Simultane-
ously, she began to have pain and stiffness in her 
shoulders, elbows, and knees, as well as in the 
interphalangeal joints of her fingers. She did not 
have Raynaud’s phenomenon, dysphagia, or heart-
burn. This constellation of findings gives rise to 
a differential diagnosis of fibrosing disorders.
Fibrosing Disorders
Skin tightening and joint stiffness are features of 
systemic fibrosing disorders (Table 3). Chronic 
kidney disease may develop in patients with sclero-
derma as a result of scleroderma renal crisis, but 
it is unusual for scleroderma to develop in patients 
with preexisting chronic kidney disease. The ab-
sence of Raynaud’s phenomenon, dysphagia, heart-
burn, and facial involvement is inconsistent with 
a diagnosis of scleroderma. Many patients with 
The New England Journal of Medicine 
Downloaded from nejm.org at UMASS WORCESTER on April 26, 2015. For personal use only. No other uses without permission. 
 Copyright © 2008 Massachusetts Medical Society. All rights reserved. 
case records of the massachusetts gener al hospital
n engl j med 358;8 www.nejm.org february 21, 2008 833
scleroderma present with circulating antinuclear 
antibodies, some of which have specificity for 
topoisomerase I (anti–Scl-70 antibodies). This pa-
tient had IgM anticardiolipin antibodies, which 
may have explained her positive result in tests for 
antinuclear antibodies (Table 1); after examining 
her, we requested testing for antibodies to topoi-
somerase I, which was negative. The absence of 
facial involvement is also inconsistent with a di-
agnosis of scleromyxedema, and the continued 
progression of her skin changes despite cortico-
steroid therapy is inconsistent with eosinophilic 
fasciitis.
Localized cutaneous fibrosing disorders such 
as morphea, scleredema diabeticorum, and lipo-
dermatosclerosis can be ruled out because the 
appearance and distribution of skin changes typi-
cal of these conditions differ from those ob-
served in this patient.
Beta2-Microglobulin Amyloidosis
This patient presented with flexion contractures 
of her hands and limited shoulder movement, 
both of which may be clinical features of beta2-
microglobulin amyloidosis, a form of amyloido-
sis that occurs exclusively in patients with chronic 
kidney disease.18 Because the hand flexion con-
tractures of beta2-microglobulin amyloidosis re-
sult from amyloid infiltration, causing the finger 
flexor tendons to adhere to one another, patients 
with this condition present with prominent sub-
cutaneous soft-tissue masses on their palms. 
This patient’s f lexion contractures were caused 
by tightening of the overlying skin, and she did 
not have soft-tissue masses on her palms.
Nephrogenic Systemic Fibrosis
This patient’s clinical presentation is most con-
sistent with nephrogenic systemic fibrosis, previ-
ously known as nephrogenic fibrosing dermopa-
thy. This condition is manifested by progressive, 
painful tightening of the skin, with tethering to 
underlying fascia, usually beginning on the hands 
and feet and extending proximally; it is associated 
with woody induration, brawny hyperpigmenta-
tion, and peau d’orange changes of affected 
skin.19 Because of the cutaneous fibrosis, contrac-
tures of the elbow, finger, knee, and ankle joints 
Table 3. Fibrosing Disorders.
Disorder Associated Features
Localized idiopathic cutaneous fibrosing  
disorders
Morphea (localized scleroderma) Circumscribed sclerotic plaques
Linear scleroderma (localized scleroderma) Circumscribed linear sclerotic plaques
Scleredema diabeticorum Neck, shoulders, and upper back affected, not the extremities; 
 diabetes mellitus
Lipodermatosclerosis Painful, brownish tightening of the skin of the lower legs — does 
not affect the arms; chronic venous insufficiency
Systemic idiopathic fibrosing disorders
Diffuse systemic sclerosis (scleroderma) Raynaud’s phenomenon, dysphagia, heartburn, facial involvement
Circulating antinuclear antibodies, including anti–topoisomerase 
I (anti–Scl-70) antibodies
Scleromyxedema Facial involvement; circulating monoclonal paraprotein (usually 
IgG lambda)
Eosinophilic fasciitis Joint stiffness, peripheral eosinophilia (intermittent)
Fibrosing disorders with identified causes
Spanish toxic oil syndrome16 Caused by olive oil adulterated with rapeseed oil
Eosinophilia–myalgia syndrome17 Caused by contamination of L-tryptophan with 1,1-ethylidenebis 
[L-tryptophan]
Graft-versus-host disease Previous bone marrow transplantation
Nephrogenic systemic fibrosis Exposure to gadolinium-containing contrast agents in the setting 
of chronic kidney disease
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develop, which significantly limit physical func-
tion. Although involvement of the trunk may oc-
casionally occur, facial involvement has not been 
described, other than characteristic yellow scleral 
plaques. Raynaud’s phenomenon and circulating 
autoantibodies are not features of nephrogenic 
systemic fibrosis.
First observed in 1997, nephrogenic systemic 
fibrosis has been described only in patients with 
kidney disease, typically those receiving dialysis 
treatment but also those who have undergone 
successful renal transplantation or have had an 
episode of acute renal failure. As many as 13% of 
patients with stage 5 chronic kidney disease have 
the skin changes that are now recognized as 
signs of nephrogenic systemic fibrosis, and these 
changes are associated with an increase in mor-
tality that is three to five times greater than that 
among patients without these skin changes.20 
Extracutaneous fibrosis involving the heart, lungs, 
diaphragm, skeletal muscle, liver, genitourinary 
tract, and central nervous system has been report-
ed.21-25 Thus, this patient’s pulmonary and car-
diac disease could also be explained by a diagno-
sis of nephrogenic systemic fibrosis.
In 2006, Grobner26 suggested a possible asso-
ciation between exposure to gadodiamide during 
magnetic resonance angiography and the devel-
opment of nephrogenic systemic fibrosis, and the 
condition has subsequently been shown to be 
strongly associated with exposure to gadolinium-
containing contrast media (e.g., gadodiamide and 
gadopentetate dimeglumine) among patients with 
stage 4 and stage 5 chronic kidney disease.22,27,28 
Gadolinium is a trivalent cation that binds strong-
ly to many tissues when it dissociates from its 
chelating agent. Although it is not known how 
gadolinium might induce fibrosis, the detection 
of gadolinium in skin-biopsy specimens from 
several patients with nephrogenic systemic fibro-
sis suggests a potential causal relationship.28,29 
This patient underwent multiple gadolinium-
enhanced magnetic resonance studies, with a to-
tal dose before our consultation of 158 ml of 
gadopentetate dimeglumine.
We recommended a biopsy of the skin to con-
firm the diagnosis.
Dr . Jonath a n K a y ’s  Di agnosis
Nephrogenic systemic fibrosis.
Pathol o gic a l Discussion
Dr. Aashiyana F. Koreishi: A skin-punch biopsy of the 
left lateral thigh showed fibrosis of the deep der-
mis, with fibrous septa extending into the subcu-
taneous tissue (Fig. 2A). Collagen bundles were 
surrounded by clefts, and an increased number 
of nuclei were present (Fig. 2B). Many CD34+ 
spindle cells were seen on immunohistochemical 
staining (Fig. 2B, inset). These findings are con-
sistent with early nephrogenic systemic fibrosis. 
The presence of CD34+ spindle cells that coex-
press procollagen-I and CD45RO is highly char-
acteristic of nephrogenic systemic fibrosis.22,30,31 
Dermal mucin deposition, fragmented and elongat-
ed elastic fibers, osseous metaplasia, osteoclast-
like giant cells, and calciphylaxis may also be 
seen. The histologic differential diagnosis includes 
scleroderma and scleromyxedema, and diagnostic 
features may not be present on skin-biopsy spec-
imens in all cases.
In light of the diagnosis of nephrogenic sys-
temic fibrosis, the specimens obtained from the 
lymph node, lung, and cardiac biopsies were re-
viewed (Fig. 2C and 2D). In retrospect, the find-
ings were consistent with nephrogenic systemic 
fibrosis. Thus, in this patient there is evidence of 
nephrogenic systemic fibrosis with cutaneous 
and systemic involvement.
Discussion of M a nagemen t
Dr. Kay: In almost all cases, nephrogenic systemic 
fibrosis progresses relentlessly. Only two cases 
have been reported in which patients had spon-
taneous improvement with resolution of acute 
renal failure.32 Mildly decreased skin thickening 
and improved joint mobility have been reported 
in seven patients treated with extracorporeal pho-
topheresis,33-35 and slight reversal of skin changes 
was observed in one other patient, who received 
treatment with pentoxifylline.28 However, other 
therapeutic approaches, such as topical and oral 
steroids, immunosuppressive drugs, intravenous 
gamma globulin, and plasmapheresis, have failed 
to improve the skin changes associated with 
nephrogenic systemic fibrosis. When I first saw 
this patient, I did not recommend specific treat-
ment. One year later, physical examination re-
vealed progression of her skin disease, including 
thickening of the skin and tethering to underly-
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ing fascia, worsening flexion contractures of the 
elbows and knees, and fixed contractures of her 
fingers. Because I had observed improvement of 
skin changes in two patients with nephrogenic 
systemic fibrosis treated with imatinib mesylate,36 
I recommended that our patient try this agent; 
however, she was unable to obtain it.
Because no treatment has yet been proven to 
be consistently effective in reversing nephro-
genic systemic fibrosis, the most effective strat-
egy is to prevent its development.
Dr. Laura L. Avery: Incidents of the development 
of nephrogenic systemic fibrosis have been report-
ed after use of each of the five available formula-
tions of gadolinium. As recommended recently 
by the Food and Drug Administration (www.fda.
gov/Cder/drug/infopage/gcca/default.htm), we in 
the Radiology Department at this hospital calcu-
late the estimated glomerular filtration rate from 
the serum creatinine level of all patients for 
whom contrast-enhanced MRI is requested. If the 
glomerular filtration rate is less than 30 ml per 
minute per 1.73 m2 of body-surface area, a gado-
linium contrast agent will not be used unless 
there is an urgent medical need, and it will be 
used in consultation with a nephrologist and after 
obtaining written informed consent. Patients re-
ceiving dialysis should not receive a gadolinium 
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Figure 2. Biopsy Specimens.
A specimen from a skin-punch biopsy from the left lateral thigh (Panel A, hematoxylin and eosin) shows fibroblastic 
expansion of dermis and fibrous septa extending into the subcutaneous tissue. Prominent collagen bundles with 
surrounding clefts and increased numbers of nuclei are seen within the dermis (Panel B, hematoxylin and eosin). 
An immunohistochemical stain (inset) reveals dermal spindle cells expressing CD34, a characteristic feature of 
nephrogenic systemic fibrosis. The paratracheal lymph-node specimen obtained from a biopsy 22 months earlier 
(Panel C, hematoxylin and eosin) shows extensive regional fibrosis, with poorly formed granulomas containing scat-
tered multinucleated giant cells (inset, hematoxylin and eosin). The lung-biopsy specimen from the same procedure 
(Panel D, hematoxylin and eosin) shows focal interstitial fibrosis with fibrous thickening of alveolar septa and focal 
ossification (inset). The findings in the lymph node and lung are consistent with nephrogenic systemic fibrosis.
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Figure 3. Autopsy Findings of Nephrogenic Systemic Fibrosis.
Examination of a histologic section obtained from the kidneys at autopsy (Panel A, hematoxylin and eosin) shows nephrocalcinosis with 
basophilic deposits within tubular basement membranes and interstitial fibrosis. Gross examination of the skin on the right upper leg 
(Panel B) shows prominent brawny induration, hyperpigmentation, and skin tightening. Histologic sections of the skin (Panel C, hema-
toxylin and eosin) reveal dense dermal fibrosis with extension into subcutaneous tissue and prominent collagen fibrils with surrounding 
clefts (arrow), elastic fibers (arrowhead), nd increased numbers of nuclei. Verhoeff elastic-tissue staining of the dermis (Panel C, inset 
on left) shows fragmented as well as elongated black elastic fibers within the dermis. Colloidal-iron staining of the dermis (Panel C, in-
set on right) shows blue-green connective-tissue mucin depositi n within the dermis. A section of the psoas muscle (Panel D, hematox-
ylin and eosin) shows the accumulation of fibrous tissue between and around muscle cells, as well as muscle-cell atrophy. The extent of 
fibrosis is highlighted with a trichrome stain (inset). A g oss external photograph of the heart (Panel E) shows patchy white areas of epi-
cardial fibrosis. A histologic section of the heart (Panel F, hematoxylin and eosin) shows fibrous tissue between cardiac myocytes (inset, 
trichrome stain). Gross and microscopical photographs of the dura (Panel G) show deposits of tan-yellow firm material on the dura (arrow), 
corresponding to focal dural thickening and calcification (inset, hematoxylin and eosin).
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contrast agent unless the radiologist and refer-
ring physician concur that the benefit to the pa-
tient outweighs the risk; hemodialysis immedi-
ately after the examination should be considered 
on an individual basis, although it has not been 
proven to be of benefit.
Dr. Cibotti-Granof: During the 15 months after 
the rheumatology evaluation, the patient was 
hospitalized several times for catheter sepsis and 
peritonitis related to dialysis. Her final admission 
was for peritonitis, which was complicated by 
pneumonia, sepsis, and sigmoid perforation. Hy-
potension and multiorgan failure developed, and 
after discussion with the family, aggressive mea-
sures were withdrawn and the patient died.
Pathol o gic a l Discussion
Dr. Koreishi: An autopsy was performed. Broncho-
pneumonia was the immediate cause of death. 
Interstitial pulmonary fibrosis was also present, 
consistent with nephrogenic systemic fibrosis. 
There was end-stage renal disease with atrophy, 
focal glomerulosclerosis, interstitial fibrosis, and 
tubular atrophy. Nephrocalcinosis was prominent 
(Fig. 3A). Gross examination of the skin revealed 
brawny induration and hyperpigmentation involv-
ing predominantly the arms and legs (Fig. 3B). 
Microscopical examination disclosed dense fibro-
sis involving the superficial and deep dermis with 
extension into the subcutaneous tissue (Fig. 3C). 
Staining of the elastic tissue highlights both 
fragmented and elongated elastic fibers (Fig. 3C, 
inset left). There was prominent connective-tissue 
mucin deposition within the dermis (Fig. 3C, in-
set right). Immunohistochemical staining again 
showed an increased number of CD34+ spindle 
cells throughout the dermis, as well as scattered 
CD68+ and factor XIIIa+ cells. There were fibro-
sis and atrophy of the diaphragm, psoas muscle 
(Fig. 3D), epicardium (Fig. 3E), and myocardium 
(Fig. 3F). There were focal areas of dural thicken-
ing and calcification (Fig. 3G).
This patient, like others who have been de-
scribed,24,37,38 had extensive systemic involvement 
by nephrogenic systemic fibrosis. Tissue blocks 
from the autopsy were sent to Dr. Whitney A. 
High’s laboratory at the University of Colorado 
Health Sciences Center for gadolinium detection 
and quantification.30,31,39,40 Gadolinium was de-
tected in all the tissue samples that were ana-
lyzed (Table 4).
Dr. Nancy Lee Harris (Pathology): Are there any 
comments or questions?
Dr. Robert B. Colvin (Pathology): Although the 
basophilic material seen in the kidneys is inter-
preted as calcium, it could also conceivably rep-
resent gadolinium deposition.
A nat omic a l Di agnosis
Nephrogenic systemic fibrosis, involving the skin, 
heart, lungs, diaphragm and psoas muscles, dura, 
and possibly the kidney.
End-stage renal disease with nephrocalcinosis.
Acute and organizing bronchopneumonia.
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